Company Profile

Twin Star Medical (AKA: Twin Star TDS LLC)
Profile last edited on: 1/12/18      CAGE: 36KF8      UEI:

Business Identifier: catheter-based technology providing site-specific tissue drainage and drug delivery
Year Founded
1998
First Award
1998
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

700 10th Avenue Suite 120
Minneapolis, MN 55415
   (612) 382-0888
   N/A
   www.twinstarmedical.com
Location: Single
Congr. District: 05
County: Hennepin

Public Profile

Twin Star Medical is a biotechnology and medical device company that is developing porous catheter designs associated with vacuum systems and infusion pumps. Twin Star's technology concept is to produce a catheter–based treatment option that is designed to perform at three levels: precise local drug infusion, pressure reduction/fluid removal, and tissue monitoring. Because of the pore redundancy, the system is able to provide even delivery/removal along the entire length of the catheter segment. Twin Star's systems have applications in a wide variety of situations, including soft tissue fluid removal and drug delivery in a variety of situations. in 2017, the company's technology for microporous catheters is limited by U.S. federal law to investigational use

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 1 NIH $339,842
Project Title: Large Volume Intratumoral Injection Device for Therapeutic Liver Infusions
2015 2 NIH $2,943,486
Project Title: Hollow Fiber Catheter for Drug Delivery Into the Prostate
2013 2 NIH $5,353,795
Project Title: Reduction of Cerebral Edema using Ventricular Therapies
2008 1 NIH $410,962
Project Title: Hollow Fiber Catheter For Drug Delivery Into The Brain
2001 2 NIH $904,679
Project Title: Treatment of cerebral edema with microdialysis

Key People / Management

  William V Fowler

  Rick Odland -- Medical Director

  Jim Stice -- Chief Executive Officer

  Richard L Sutton

  Scott Wilson -- Director of Product Development